These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27156124)

  • 21. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fatal blood concentration of 5-APB.
    Krpo M; Luytkis HC; Haneborg AM; Høiseth G
    Forensic Sci Int; 2018 Oct; 291():e1-e3. PubMed ID: 30228015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combined toxicokinetic and metabolic approach to investigate deschloro-N-ethylketamine exposure in a multidrug user.
    Magny R; Mégarbane B; Chevillard L; Roulland E; Bardèche-Trystram B; Dumestre-Toulet V; Labat L; Houzé P
    J Pharm Biomed Anal; 2024 Jun; 243():116086. PubMed ID: 38518457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing of 2-MAPB and 6-MAPB: Solution of the problem.
    Shevyrin V; Shafran Y
    J Mass Spectrom; 2017 Oct; 52(10):633-637. PubMed ID: 28708288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine.
    Vermette-Marcotte AE; Dargan PI; Archer JR; Gosselin S; Wood DM
    Clin Toxicol (Phila); 2014 Aug; 52(7):678-81. PubMed ID: 25089723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of psychoactive 'bath salts' use during pregnancy.
    Gray BA; Holland C
    Nurs Womens Health; 2014; 18(3):220-30. PubMed ID: 24939199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems.
    Welter-Luedeke J; Maurer HH
    Ther Drug Monit; 2016 Feb; 38(1):4-11. PubMed ID: 26327309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmortem distribution and redistribution of MDAI and 2-MAPB in blood and alternative matrices.
    Staeheli SN; Boxler MI; Oestreich A; Marti M; Gascho D; Bolliger SA; Kraemer T; Steuer AE
    Forensic Sci Int; 2017 Oct; 279():83-87. PubMed ID: 28850871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Death following consumption of MDAI and 5-EAPB.
    Deville M; Dubois N; Cieckiewicz E; De Tullio P; Lemaire E; Charlier C
    Forensic Sci Int; 2019 Jun; 299():89-94. PubMed ID: 30981086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural confirmation of position isomers 2-(2-methylaminoprolyl)benzofuran and 5-(2-methylaminopropyl)benzofuran: a combined mass spectrometric and computational study.
    Xu Y; Lin X; Chen X; Ke X; Wu H; Fan YL; Zhou J; Xu J
    Rapid Commun Mass Spectrom; 2024 Feb; 38(4):e9688. PubMed ID: 38212651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cristalius: a case in designer drugs.
    Lenz J; Brown J; Flagg S; Oh R; Batts K; Ditzler T; Johnson J
    Mil Med; 2013 Jul; 178(7):e893-5. PubMed ID: 23820374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.
    Hill SL; Doris T; Gurung S; Katebe S; Lomas A; Dunn M; Blain P; Thomas SH
    Clin Toxicol (Phila); 2013 Jul; 51(6):487-92. PubMed ID: 23731373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
    Gomila I; Moranta C; Quesada L; Pastor Y; Dastis M; Torrents A; Elorza MÁ; Busardò FP; Barceló B
    Bioanalysis; 2017 Nov; 9(22):1771-1785. PubMed ID: 28975809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
    Wood DM; Greene SL; Dargan PI
    Emerg Med J; 2011 Apr; 28(4):280-2. PubMed ID: 20581379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecstasy abuse in Ireland.
    Cregg MT; Tracey JA
    Ir Med J; 1993; 86(4):118-20. PubMed ID: 8103042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
    Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
    Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden cardiac death associated with methylone use.
    Carbone PN; Carbone DL; Carstairs SD; Luzi SA
    Am J Forensic Med Pathol; 2013 Mar; 34(1):26-8. PubMed ID: 23403480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.
    Darracq MA; Thornton SL; Minns AB; Gerona RR
    J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.